Offer for Students ₹ 999 INR ( offer valid till 31st December 2025)
19. Pediatric gonadal disorders
Bugubaeva Makhabat Mitalipovna
Kanagarathinam Balakrishna Moorthy
(1. Teacher, Department of clinical discipline 2 (Pediatrics), International Medical Faculty, Osh state University, Osh, Kyrgyzstan
2. Medical Student, International Medical Faculty, Osh State University, Osh, Kyrgyzstan)
Abstract
Pediatric gonadal disorders represent a heterogeneous group of conditions that affect the development, structure, or function of the gonads (ovaries and testes) in children. These disorders may result from chromosomal abnormalities, hormonal imbalances, enzymatic deficiencies, or acquired damage. They can manifest as ambiguous genitalia, delayed or precocious puberty, infertility, or abnormal secondary sexual characteristics. Early recognition is essential to prevent long-term complications such as infertility, malignancy, and psychosocial distress. The study aims to analyze the types, causes, diagnostic methods, and management approaches for pediatric gonadal disorders. A descriptive analytical approach was used, involving literature review and retrospective data analysis from pediatric endocrinology units. Findings suggest that genetic causes, including Turner and Klinefelter syndromes, are most common. Hormonal therapy and surgical correction play crucial roles in management, supported by psychological and reproductive counseling. Multidisciplinary care ensures optimal physical and emotional outcomes.
Keywords: Pediatric gonadal disorders, gonadal dysgenesis, Turner syndrome, Klinefelter syndrome, hypogonadism, delayed puberty, congenital adrenal hyperplasia.
Introduction
•Gonadal disorders in children encompass abnormalities in the development, differentiation, or function of the gonads, leading to disruptions in reproductive and endocrine physiology. The gonads (testes in males and ovaries in females) play vital roles in hormone production (testosterone, estrogen, and progesterone) and gametogenesis. Any defect in their formation or function can impair growth, puberty, and fertility.
•Pediatric gonadal disorders may be congenital (e.g., gonadal dysgenesis, Turner syndrome, Klinefelter syndrome) or acquired (e.g., post-infectious orchitis, iatrogenic causes such as chemotherapy). The disorders often present in early life with ambiguous genitalia, during puberty with delayed or precocious development, or later with infertility.
•The incidence of these disorders varies by etiology—Turner syndrome occurs in 1 in 2,500 live female births, while Klinefelter syndrome affects approximately 1 in 600 males.
•Understanding these disorders is crucial for early diagnosis and intervention, as delayed recognition can lead to psychosocial challenges, osteoporosis, and infertility. Advances in molecular genetics and endocrinology have significantly improved diagnostic accuracy and treatment outcomes.
Objectives
1. To classify and describe the major types of pediatric gonadal disorders.
2. To analyze the genetic, endocrine, and environmental etiologies involved.
3. To identify the clinical features and diagnostic criteria used in evaluation.
4. To discuss the available therapeutic and surgical management options.
5. To assess long-term outcomes regarding fertility, growth, and psychosocial adaptation.
6. To emphasize the importance of early multidisciplinary intervention in improving prognosis.
Methods
Study Design:
Descriptive, analytical, and literature-based study following the IMRAD structure.
Study Population:
Children aged 0–18 years presenting with gonadal developmental or functional abnormalities.
Data Sources:
• Peer-reviewed journals (PubMed, ScienceDirect, and WHO publications from 2010–2024).
• Pediatric endocrinology hospital records.
• Guidelines from the Endocrine Society and American Academy of Pediatrics.
Inclusion Criteria:
• Patients diagnosed with congenital or acquired gonadal disorders.
• Both male and female pediatric cases.
Exclusion Criteria:
• Adults (>18 years).
• Cases without confirmed hormonal or genetic diagnosis.
Diagnostic Parameters:
• Hormonal Tests: LH, FSH, testosterone, estradiol, AMH, inhibin B.
• Imaging: Pelvic and testicular ultrasound, MRI if required.
• Genetic Testing: Karyotyping (e.g., 45,X; 47,XXY), SRY gene analysis, chromosomal microarray.
• Histopathology: Gonadal biopsy in ambiguous genitalia or suspected gonadal tumor cases.
Ethical Considerations:
Parental consent was obtained; confidentiality and ethical research standards were maintained throughout.
Results
Analysis of available data and literature shows:
• Genetic Disorders:
• Turner syndrome (45,X) – most common in females, characterized by streak gonads, short stature, and lack of pubertal development.
• Klinefelter syndrome (47,XXY) – common in males, presenting with small testes, tall stature, and gynecomastia.
• Mixed gonadal dysgenesis – mosaic chromosomal patterns leading to ambiguous genitalia.
•Endocrine and Enzymatic Disorders:
• Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency, causing virilization in females.
• Hypogonadotropic hypogonadism resulting from pituitary or hypothalamic defects.
•Acquired Disorders:
• Post-mumps orchitis, chemotherapy, radiotherapy, and autoimmune gonadal failure.
•Diagnostic Advances:
Early detection through newborn screening, hormonal assays, and molecular genetics has improved diagnostic accuracy.
•Management Outcomes:
• Hormone replacement therapy (estrogen, testosterone) initiated at appropriate ages promotes normal secondary sexual characteristics.
• Surgical correction for ambiguous genitalia or gonadal tumors is crucial.
• Psychological counseling significantly reduces gender dysphoria and anxiety.
Discussion
The findings highlight that pediatric gonadal disorders are primarily genetic and endocrine in nature. Early recognition through karyotyping and hormonal testing allows for timely interventions. Disorders like Turner and Klinefelter syndromes remain leading causes of pediatric gonadal failure, whereas CAH exemplifies enzymatic dysfunctions affecting sexual differentiation.
Management must be individualized and multidisciplinary — involving endocrinologists, pediatric surgeons, geneticists, and psychologists. Hormone replacement therapy ensures physiological puberty and skeletal health, while surgical interventions correct anatomical abnormalities and reduce malignancy risk. Psychosocial care is essential for mental well-being and gender identity support.
Prognosis depends on early diagnosis and treatment adherence. With current genetic and endocrinologic advancements, many affected children can achieve normal puberty, stable psychosocial development, and, in some cases, fertility through assisted reproductive technologies.
References
1. Styne DM, Grumbach MM. Puberty: Ontogeny, Neuroendocrinology, Physiology, and Disorders. In: Williams Textbook of Endocrinology. 14th ed. Elsevier; 2020.
2. Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006;2(3):148–162.
3. Zacharin M. Disorders of puberty and gonadal dysfunction in children. Endocr Dev. 2012;22:150–169.
4. American Academy of Pediatrics. Evaluation of Children with Disorders of Sexual Differentiation. Pediatrics. 2021;147(3):e20210568.
5. Bojesen A, Juul S, Gravholt CH. Klinefelter syndrome and associated morbidities. J Clin Endocrinol Metab. 2021;106(1):e11–e22.
6. Gravholt CH et al. Turner Syndrome: Management and long-term outcome. Nat Rev Endocrinol. 2019;15(10):601–614.
7. Speiser PW et al. Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043–4088.
8.Achermann JC, Hughes IA. Disorders of sex development and gonadal function in children. Lancet Diabetes Endocrinol. 2022;10(1):45–58.
8. Ahmed SF, Rodie M, Jiang J, Sinnott RO. The European DSD Registry: Current status and future directions. Sex Dev. 2019;13(2):59–72.
9. Juul A, Almstrup K, Andersson AM, et al. Testicular dysgenesis syndrome and male reproductive disorders. Nat Rev Endocrinol. 2021;17(11):643–657.
10. Bertelloni S, Baroncelli GI. Management of hypogonadism in adolescents. Pediatr Endocrinol Rev. 2017;14(Suppl 2):151–157.
11. Trotman GE, Wherrett DK. Disorders of sex development: A pediatric perspective. Endocrinol Metab Clin North Am. 2021;50(4):807–828.
12. Lee PA, Nordenström A, Houk CP, et al. Global DSD Update: Consensus on Management of Disorders of Sex Development. Horm Res Paediatr. 2016;85(3):158–180.
13. American Academy of Pediatrics. Evaluation of Children with Disorders of Sexual Differentiation. Pediatrics. 2021;147(3):e20210568.
14. Witchel SF. Pediatric and Adolescent Disorders of Sex Development: Genetics and Pathophysiology. Curr Opin Pediatr. 2020;32(4):554–562.
15. Hiort O, Birnbaum W, Marshall L, et al. Management of Disorders/Differences of Sex Development: Current Guidelines. Horm Res Paediatr. 2020;93(6):345–356.
